Ergoteles LLC Adaptive Biotechnologies Corp Transaction History

Ergoteles LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$6.4 - $14.73 $304,000 - $699,675	-47,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $59,070 - $168,689	5,837 Added 14.01%	47,500 $659,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $1.05 Million - $1.54 Million	41,663 New	41,663 $1.17 Million
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $5.79 Million - $8.01 Million	-179,680 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$37.26 - $67.74 $6.69 Million - $12.2 Million	179,680 New	179,680 $7.23 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.